Company
Jotbody (HK) Limited is a pioneering biotechnology company specialising in the discovery and development of nanobodies derived from camelids and sharks. Our cutting-edge expertise allows us to leverage these unique biological sources to create highly specific and versatile therapeutic agents.
In addition to our focus on nanobodies, Jotbody is also at the forefront of research in extracellular vesicles, commonly known as exosomes. We excel in the isolation, characterisation, and functionalization of these biological nanoparticles, enabling us to unlock their potential for a wide range of applications in diagnostics and therapeutics.
Description
Jotbody (HK) Limited, established in 2020 as a spin-off from City University of Hong Kong, is a cutting-edge biotechnology company specialising in nanobody research and extracellular vesicles (EVs). With a team of experienced scientists and dedicated board members, Jotbody is committed to advancing global research and development in its field. The company has garnered recognition for its innovative contributions, being listed in FORBES ASIA 100 to Watch
